Safety and Immunogenicity Study of tgAAC09, an HIV Vaccine in an Adeno-associated Virus (AAV) Capsid (TGC14F)

This study has been completed.
Sponsor:
Collaborator:
Targeted Genetics Corporation
Information provided by (Responsible Party):
International AIDS Vaccine Initiative
ClinicalTrials.gov Identifier:
NCT00888446
First received: April 23, 2009
Last updated: December 13, 2012
Last verified: December 2012